Print this page    •   Back to Web version of article

Medical News
Prevalence of Drug-Resistant HIV Has Fallen Dramatically Among Antiretroviral-Experienced Patients in Western Europe

January 24, 2013

New effective and easy-to-use treatments are responsible for a decline in the number of HIV-infected Western Europeans with resistance to antiretroviral drugs, according to researchers. Between 27 and 32 percent of HIV-infected people were resistant to all treatments in 2000; by 2008, the proportion had dropped to 0.3 to one percent of HIV-infected people.

When HIV becomes resistant, the virus can replicate and cause illness and death. Early one- or two-drug regimens could not suppress HIV over time, and resulted in drug-resistant HIV. Triple therapy regimens, introduced in 1996, were not always effective against the drug-resistant HIV. Early three-pill combinations also were weaker, caused side effects, and required strict adherence. Triple therapies developed in the last 10 years are safer, more potent, and easier to use.

The study reviewed 20,323 people treated with anti-HIV drugs between 1997 and 2008 in seven Western European countries. Study participants were mostly men (74 percent), and 64 percent were infected with HIV subtype B. More than half of the group had taken one- or two-drug therapies for HIV. The participants had taken antiretroviral drugs for a median of 64 months when genotyping of their HIV virus took place. Most participants (80 percent) had a mutated virus that was resistant to at least one of the three main types of antiretroviral drugs.

However, resistance to nucleoside reverse transcriptase inhibitors and protease inhibitors decreased after 2001. Resistance to non-nucleoside reverse transcriptase inhibitors began to fall after 2004. Triple-class resistance started to fall after 2005.

The full report, "Declining prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-Exposed Individuals in Western Europe," was published online in the Journal of Infectious Diseases (2013; doi: 10.1093/infdis/jit017).

Back to other news for January 2013

Excerpted from:
01.22.2013; Michael Carter

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.